Recent Publications
- Asanad K, Halpern JA, Brannigan RE.
JAMA. 2024 Mar 21. doi: 10.1001/jama.2023.26934. Online ahead of print.
- Madhvapathy SR, Bury MI, Wang LW, Ciatti JL, Avila R, Huang Y, Sharma AK, Rogers JA.
Nat Biomed Eng. 2024 Mar 18. doi: 10.1038/s41551-024-01183-w. Online ahead of print.
Comparison of Magnetic Resonance Imaging-Based Risk Calculators to Predict Prostate Cancer Risk.
Patel HD, Remmers S, Ellis JL, Li EV, Roobol MJ, Fang AM, Davik P, Rais-Bahrami S, Murphy AB, Ross AE, Gupta GN.JAMA Netw Open. 2024 Mar 4;7(3):e241516. doi: 10.1001/jamanetworkopen.2024.1516.
Safety and Diagnostic Efficacy of Image-Guided Biopsy of Small Renal Masses.
Serhal M, et al. Among authors: perry kt jr.Cancers (Basel). 2024 Feb 19;16(4):835. doi: 10.3390/cancers16040835.
- Hung M, Ross AE, Li EV, Pavlovich CP, Fletcher SA, Gereta S, Zhang TR, McClure TD, Allaf ME, Schaeffer EM, Hu JC.
Urology. 2024 Feb 20:S0090-4295(24)00093-1. doi: 10.1016/j.urology.2023.11.039. Online ahead of print.
Novel reference range values for serum testosterone: a cross-sectional study of 200,000 males.
Fantus RJ, Greenberg DR, Chang C, Helfand BT, Xu J, Wei J, Shoag JE, Nangia AK, Brannigan RE, Halpern JA.J Endocrinol Invest. 2024 Feb 22. doi: 10.1007/s40618-024-02319-0. Online ahead of print.
- Bury MI, et al. Among authors: hofer md, mckenna ke, cheng ey, sharma ak.
PNAS Nexus. 2024 Jan 30;3(2):pgae038. doi: 10.1093/pnasnexus/pgae038. eCollection 2024 Feb.
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer.
Spratt DE, et al. Among authors: schaeffer em.NEJM Evid. 2023 Aug;2(8):EVIDoa2300023. doi: 10.1056/EVIDoa2300023. Epub 2023 Jun 29.
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer.
Gharzai LA, et al. Among authors: schaeffer em.NEJM Evid. 2023 Apr;2(4):EVIDoa2200195. doi: 10.1056/EVIDoa2200195. Epub 2023 Mar 27.
- Ross AE, et al. Among authors: schaeffer em.
Eur Urol Oncol. 2024 Jan 31:S2588-9311(24)00029-4. doi: 10.1016/j.euo.2024.01.004. Online ahead of print.